Prenatal Diagnostic Center, a provider of genetic laboratory services, retained Shields & Company to identify a suitable acquirer and negotiate a transaction that would maximize shareholder value. The sale process resulted in the company's acquisition by the Genzyme Corporation, and the company's shareholders received liquidity for their ownership interest.
Shields & Company acted as a financial advisor to Prenatal Diagnostic Center, Inc. in the above transaction.